Open Exploration Publishing Inc. is proud to announce that its journals, Exploration of Medicine (EM) and Exploration of Targeted Anti-tumor Therapy (ETAT), have achieved their first Scopus CiteScore this month. This significant achievement follows their acceptance into Scopus in March 2022. 

EM (https://www.scopus.com/sourceid/21101088221):

2022 CiteScore: 1.8

CiteScore Tracker in June, 2023: 2.4

ETAT (https://www.scopus.com/sourceid/21101088220):

2022 CiteScore: 1.7

CiteScore Tracker in June, 2023: 2.6

CiteScore is a widely recognized metric reflects the citation impact of a journal’s research-based contributions with greater stability and consistency in applied time ranges, indicating the impact of a journal within the scientific community. The attainment of the first CiteScore by EM and ETAT signifies their growing recognition and importance of their published research among researchers, scholars, and professionals globally. The rising scores indicate that EM and ETAT are experiencing a promising upward trend.

With Scopus indexing, we will continue the Free Publication Policy to relieve the financial burden for researchers. Meanwhile, we also set the policy of Highly Cited Paper Award to recognize the high quality articles, and to promote the better development of our journals. We always welcome scholars, researchers, and professionals in the scientific communities to actively participate and contribute their valuable insights to our journals.